| |
| Genus, Inc. |
| Condensed Consolidated Statement of Operations (Unaudited) |
| (Amounts in thousands, except per share data) |
| |
|
|
|
| |
Three
Months Ended |
|
Three
Months Ended |
| |
March
31, 2001 |
|
March
31, 2000 |
| |
|
|
|
| Net sales |
$ 14,309
|
|
$ 3,826
|
| |
|
|
|
| Costs
and expenses: |
|
|
|
| Cost
of goods sold |
8,603
|
|
2,844
|
| Research
and development |
3,004
|
|
1,760
|
| Selling,
general and administrative |
2,518
|
|
2,825
|
| Income(loss)
from operations |
184
|
|
(3,603) |
| |
|
|
|
| Other,
net |
2 |
|
286
|
| Income(loss)
before income taxes |
186
|
|
(3,317) |
| |
|
|
|
| Provision
for income taxes |
55 |
|
250
|
| |
|
|
|
| Net income(loss)
before cumulative |
|
|
|
| effect
of change in accounting principle |
131
|
|
(3,567) |
| |
|
|
|
| Cumulative
effect of change in accounting principle |
- |
|
(6,770) |
| |
|
|
|
| Net income(loss)
|
$ 131
|
|
$ (10,337) |
| |
|
|
|
| Net income(loss)
per common share and |
|
|
|
| per common
share assuming basic shares |
$ 0.01
|
|
$ (0.56) |
| |
|
|
|
| Net income(loss)
per common share and |
|
|
|
| per common
share assuming dilution |
$ 0.01
|
|
$ (0.56) |
| |
|
|
|
| Shares
used in per share calculations-basic |
19,379
|
|
18,569
|
| Shares
used in per share calculations-diluted |
19,926
|
|
18,569
|
| |
|
|
|
|
| |
| Condensed
Consolidated Balance Sheets (Unaudited) |
| (Amounts
in thousands) |
| |
| |
|
|
|
| |
March 31,
2001
|
|
December
31, 2000
|
| Assets |
|
|
|
| Cash
and cash equivalents |
$ 3,092
|
|
$ 3,136
|
| Accounts
receivable, net |
5,034
|
|
8,479
|
| Inventories
* |
19,143
|
|
21,849
|
| Other
current assets |
689
|
|
675
|
| Total
current assets |
27,958
|
|
34,139
|
| |
|
|
|
| Equipment,
furniture and fixtures, net |
13,279
|
|
10,207
|
| Other
assets, net |
183
|
|
189
|
| Total
assets |
$ 41,420
|
|
$ 44,535
|
| |
|
|
|
| Liabilities,
redeemable preferred stock, and shareholders' equity |
|
|
|
| Deferred
revenue |
$ 14,673
|
|
$ 18,562
|
| Other
current liabilities |
15,199
|
|
14,681
|
| Shareholders'
equity |
11,548
|
|
11,292
|
| Total
liabilities, redeemable preferred stock, and shareholders' equity |
$ 41,420
|
|
$ 44,535
|
|
|